Diametrics seeks to add creatinine to POC (point-of-care) analyser:
This article was originally published in Clinica
Executive Summary
Diametrics Medical has filed a 510(k) marketing application to the US FDA for permission to add a creatinine test to the menu of assays that are run on its point-of-care IRMA SL blood analysis system. Creatinine measurements can help clinicians diagnose and treat renal diseases as well as monitor the renal status of patients in intensive care units. The IRMA system is a portable device that performs a broad range of time-critical tests at the patient's bedside, including blood gases, electrolytes, chemistries and haematocrit, in just 90 seconds.
You may also be interested in...
Investors Go Berserk For Viking, Putting It Top Of Q1 Winners
The top 10 biggest share price winners and losers in Q1 from Evaluate show the investor frenzy for obesity drugs continues, while companies with governance doubts see shareholders retreat.
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.